MedTrace Logo

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

NCT07039461 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2026-01-06

No results posted yet for this study

Summary

To study the effectiveness and safety of IPL treatment for Chalazion

Conditions

  • Chalazion

Interventions

DEVICE

OptiLIGHT

three IPL or sham treatment in 1 week interval followed by 1 follow-up 4 weeks after the last treatment

Sponsors & Collaborators

  • Lumenis Be Ltd.

    lead INDUSTRY

Principal Investigators

  • James Chelnis, MD · Manhattan Face and Eye

  • Laura Periman, MD · Periman Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-12
Primary Completion
2025-12-24
Completion
2025-12-24
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07039461 on ClinicalTrials.gov